Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma
NCT07411144
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Pleural Mesothelioma (DPM)
Interventions
DRUG:
Gemcitabine (1000 mg/m2)
Sponsor
National Cancer Institute, Egypt